Novo Nordisk wins USFDA nod for oral diabetes drug Rybelsus Medical Dialogues Bureau23 Sept 2019 2:16 PM ISTNovo Nordisk did not disclose what it plans to charge for the new oral treatment, called Rybelsus, but said it would be "competitively priced" with...
Novo Nordisk wins EU panel's backing for key diabetes drug Ruby Khatun Khatun18 Dec 2017 10:30 AM ISTCOPENHAGEN: Danish drugmaker Novo Nordisk came closer to winning European approval for diabetes drug Ozempic, it's biggest growth prospect when a...
FDA approves Novo Nordisk diabetes drug Ozempic Ruby Khatun Khatun6 Dec 2017 10:30 AM ISTThe U.S. Food and Drug Administration on Tuesday approved Novo Nordisk A/S's diabetes drug Ozempic, setting the stage for a heated battle with Eli...
Under pressure in diabetes, Novo Nordisk steps up focus on obesity drugs Ruby Khatun Khatun24 Nov 2017 9:30 AM ISTDenmark: Danish drugmaker Novo Nordisk is stepping up its efforts to treat obesity, seeking to tap into a potentially huge market as prices for its...